Header

UZH-Logo

Maintenance Infos

Pharmacokinetics and dosage adjustment of cefotiam in renal impaired patients


Rouan, M C; Binswanger, U; Bammatter, F; Theobald, W; Schoeller, J P; Guibert, J (1984). Pharmacokinetics and dosage adjustment of cefotiam in renal impaired patients. Journal of Antimicrobial Chemotherapy, 13(6):611-618.

Abstract

The pharmacokinetics of cefotiam were investigated after intravenous administration of 1 g to 2 healthy volunteers with normal renal function and to 16 patients whose creatinine clearance ranged from 4.7 to 0.11/h (78 to 1.66 ml/min). The elimination half-life varied from 1.1 h in normal subjects to 13 h in patients and the total plasma clearance from 21 to 0.6 1/h (350 to 10 ml/min). The urinary recovery decreased from 62% of the dose in normal subjects to 1.1% in patients, and the renal clearance from 15 to 0.03 l/h (250 to 0.5 ml/min). Plasma and renal clearances of cefotiam correlated well with the creatinine clearance. The dosage schedule for cefotiam in patients with normal renal function can be used in the presence of renal failure when the creatinine clearance is equal to or greater than 1 1/h (16.6 ml/min). For patients whose creatinine clearance is less than 1 1/h, the dose must be decreased to 75% of that for a patient with normal renal function only when it is given every 6 or 8 h

Abstract

The pharmacokinetics of cefotiam were investigated after intravenous administration of 1 g to 2 healthy volunteers with normal renal function and to 16 patients whose creatinine clearance ranged from 4.7 to 0.11/h (78 to 1.66 ml/min). The elimination half-life varied from 1.1 h in normal subjects to 13 h in patients and the total plasma clearance from 21 to 0.6 1/h (350 to 10 ml/min). The urinary recovery decreased from 62% of the dose in normal subjects to 1.1% in patients, and the renal clearance from 15 to 0.03 l/h (250 to 0.5 ml/min). Plasma and renal clearances of cefotiam correlated well with the creatinine clearance. The dosage schedule for cefotiam in patients with normal renal function can be used in the presence of renal failure when the creatinine clearance is equal to or greater than 1 1/h (16.6 ml/min). For patients whose creatinine clearance is less than 1 1/h, the dose must be decreased to 75% of that for a patient with normal renal function only when it is given every 6 or 8 h

Statistics

Citations

Dimensions.ai Metrics
6 citations in Web of Science®
5 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

28 downloads since deposited on 18 Oct 2018
9 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:National licences > 142-005
Dewey Decimal Classification:570 Life sciences; biology
610 Medicine & health
Scopus Subject Areas:Life Sciences > Pharmacology
Health Sciences > Microbiology (medical)
Health Sciences > Infectious Diseases
Health Sciences > Pharmacology (medical)
Language:English
Date:1 January 1984
Deposited On:18 Oct 2018 12:27
Last Modified:15 Apr 2021 14:51
Publisher:Oxford University Press
ISSN:0305-7453
OA Status:Green
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1093/jac/13.6.611

Download

Green Open Access

Download PDF  'Pharmacokinetics and dosage adjustment of cefotiam in renal impaired patients'.
Preview
Content: Published Version
Language: English
Filetype: PDF (Nationallizenz 142-005)
Size: 371kB
View at publisher